Blog Archives
Senate President Therese Murray is the MassBio Legislator of the Year!
Geoff MacKay, President & CEO of Organogenesis and Chairman of the MassBio Board of Directors (left), Senate President Therese Murray, and Bob Coughlin, President & CEO of MassBio.
Yesterday, we held the MassBio Annual Policy Leadership Breakfast. Thank you to all of our speakers, sponsors, and attendees for making it a very successful event! We will do an event recap that includes video footage and the panel discussion on biosimilars soon, but today we wanted to be sure to congratulate Senate President Therese Murray who was named the MassBio Legislator of the Year!
Senate President Murray has been proactive in forging strong relationships for Massachusetts with leaders abroad and, this year, led us as we welcomed the BIO International Convention back to Boston. She and her colleagues participated in the Massachusetts Pavilion and met with numerous global companies and organizations to educate them on the benefits of being involved in the leading life sciences cluster in the world, resulting in tangible wins for the Commonwealth and patients everywhere.
HBA’s Upcoming Healthcare Forum: Impact of Healthcare Reform on Innovation
Our partners over at the Healthcare Businesswomen’s Association (HBA) Boston chapter recently announced their upcoming Healthcare Forum. This will be a dynamic, multi-sector panel of Boston healthcare leaders who will discuss the impact of healthcare reform on innovation and their company strategies. It promises to be an engaging event, so we wanted to be sure to share it with our readers here.
The Forum will be held on Thursday, September 13, 2012 from 5:30 – 9:00 pm at the Langham Hotel, 250 Franklin Street, Boston. Local healthcare business leaders will discuss how reform and regulation are driving and inhibiting innovation across the spectrum of healthcare businesses in Boston. In this time of transition, these thought leaders will speak about how their organizations are using new business models, novel partnerships, and out-of-the-box thinking to change how healthcare is delivered.
Martha Bebinger, WBUR Healthcare Reporter, will moderate the panel of distinguished speakers including:
- Naomi Fried, Chief Innovation Officer, Children’s Hospital Boston
- Justine M. Carr, M.D., CMO, Steward Health Care System
- Nancy J. Gagliano, M.D., CMO, CVS MinuteClinic
- Tamima Itani, Vice President of Global Regulatory Affairs and Regulatory Compliance, Boston Scientific Corporation
- Christina Severin, President, Network Health
- Samantha Singer, Vice President of Corporate Strategy, Biogen Idec.
“This forum is designed to allow attendees to obtain new awareness of changes being driven right here in Boston in all healthcare sectors, understanding of the impact of reform on their roles and their companies,” said Keri Collette, President of the HBA Boston chapter. “The event will offer network-building opportunities as well, because we believe that this will spark stimulating dialogue both at the event and going forward.”
To register and see details of event information, visit www.hbanet.org/Boston.
Top 5 News Stories 8/6 – 8/10
1) Patrick signs bill tackling health care costs Wicked Local – 08/06/2012
Gov. Deval Patrick signed a sweeping health care reform law on Monday that seeks to build on the state’s near universal access to insurance by reining in costs and improving the quality and transparency of care. As it did for former Gov. Mitt Romney, the bill holds the potential, for better or worse, to become a defining accomplishment for both Patrick and the House and Senate leaders who crafted the legislation.
2) OvaScience ups most recent round to $4M Mass High Tech – 08/06/2012
Fertility treatment startup OvaScience Inc. has added another $2.5 million and 75 new investors to an equity offering it first reported in early July, bringing the total amount the company has raised this year to more than $40 million. A federal filing Monday is the company’s second amendment to one first filed on July 5. The amendment raises the amount the company is reporting to have raised from $1.6 million to $4 million, and says there are now 116 investors involved in the round, an increase from 41 in July.
